# A Safety Study of LY3493269 Given as a Single Injection in Healthy Participants

> **NCT04178733** · PHASE1 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 33 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** LY3493269 - SC
- **DRUG:** Placebo - SC
- **DRUG:** LY3493269 - IV

## Key facts

- **NCT ID:** NCT04178733
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-01-10
- **Primary completion:** 2020-05-11
- **Final completion:** 2020-05-11
- **Target enrollment:** 33 (ACTUAL)
- **Last updated:** 2025-01-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04178733

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04178733, "A Safety Study of LY3493269 Given as a Single Injection in Healthy Participants". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT04178733. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*